Geneva, March 20 -- International Clinical Trials Registry received information related to the study (RBR-9hdghd3) titled 'Esmolol or Remifentanil: a comparison of medications during maxillofacial surgery and patient recovery' on Feb. 25.
Study Type: Intervention
Study Design:
a phase 4, randomized-controlled, double-blind, parallel, treatment
Primary Sponsor: Empresa Brasileira De Servicos Hospitalares
Condition:
Postprocedural disorder of digestive system, unspecified
Convalescence following surgery
Other complications of procedures, not elsewhere classified
E03.155.308
Intervention:
This is a randomized, double-blind, single-center clinical trial with prospective evaluation and parallel control. The study will be conducted at O...